1. Home
  2. ANGI vs AMLX Comparison

ANGI vs AMLX Comparison

Compare ANGI & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGI
  • AMLX
  • Stock Information
  • Founded
  • ANGI 1995
  • AMLX 2014
  • Country
  • ANGI United States
  • AMLX United States
  • Employees
  • ANGI N/A
  • AMLX N/A
  • Industry
  • ANGI Advertising
  • AMLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANGI Consumer Discretionary
  • AMLX Health Care
  • Exchange
  • ANGI Nasdaq
  • AMLX Nasdaq
  • Market Cap
  • ANGI 791.5M
  • AMLX 749.9M
  • IPO Year
  • ANGI 2017
  • AMLX 2022
  • Fundamental
  • Price
  • ANGI $18.30
  • AMLX $10.20
  • Analyst Decision
  • ANGI Hold
  • AMLX Strong Buy
  • Analyst Count
  • ANGI 8
  • AMLX 7
  • Target Price
  • ANGI $21.17
  • AMLX $12.29
  • AVG Volume (30 Days)
  • ANGI 584.5K
  • AMLX 1.3M
  • Earning Date
  • ANGI 08-05-2025
  • AMLX 08-07-2025
  • Dividend Yield
  • ANGI N/A
  • AMLX N/A
  • EPS Growth
  • ANGI N/A
  • AMLX N/A
  • EPS
  • ANGI 1.20
  • AMLX N/A
  • Revenue
  • ANGI $1,088,722,000.00
  • AMLX N/A
  • Revenue This Year
  • ANGI N/A
  • AMLX N/A
  • Revenue Next Year
  • ANGI $4.89
  • AMLX N/A
  • P/E Ratio
  • ANGI $15.24
  • AMLX N/A
  • Revenue Growth
  • ANGI N/A
  • AMLX N/A
  • 52 Week Low
  • ANGI $10.88
  • AMLX $2.09
  • 52 Week High
  • ANGI $29.15
  • AMLX $10.20
  • Technical
  • Relative Strength Index (RSI)
  • ANGI 57.88
  • AMLX 69.71
  • Support Level
  • ANGI $17.47
  • AMLX $9.15
  • Resistance Level
  • ANGI $17.82
  • AMLX $10.06
  • Average True Range (ATR)
  • ANGI 0.63
  • AMLX 0.54
  • MACD
  • ANGI -0.03
  • AMLX 0.12
  • Stochastic Oscillator
  • ANGI 79.53
  • AMLX 98.53

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: